Sunday, June 1, 2025
20.6 C
Bengaluru

Frontline Managers

[wpfilebase tag=file id=62 tpl=download-button /]

Inside this Issue

1. Parle-G: Still Number One by Vivek Hattangadi

How this 80 year old brand still has 80 percent market share.

2. The University of Pharma Sales by Raja Reddy

What the author learned about success and life on his journey from Medical Representative to Group Product Manager.

3. Nine Accountability Boosters for Frontline Managers by K. Hariram

9 habits that will inspire the confidence of your team members in your Leadership.

4. Bridging the Trust Deficit by Satish Kota

Indian Pharma has contributed immensely to society but needs an image makeover to change negative perceptions.

5. Impact of Frontline Leadership on Efficiency: A Case Study by P. S. Parameswaran

The actions of the Frontline Manager, more than anything else, has a direct impact on how employees perform.

6. Cost-Effective Learning by Gopal Kishore

Using technology to make learning personalized is both cost effective and impactful.

7. Smart Pills by Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, Mahendra Kumar Rai

Are ingestible sensors the next big thing in patient adherence?

Hot this week

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?

Tata 1mg App Business Model: How does it work...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

Topics

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable...

Nimesulide – Nice or Not Nise?

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...
spot_img

Related Articles

spot_imgspot_img